A short peptide from Vladimir Khavinson’s bioregulator programme directed at testicular tissue and studied in the context of androgen production.

Why are the testes described as unusually sensitive?

Because sperm production does not run properly at core body temperature — the tissue sits outside the body specifically to stay a few degrees cooler. Very few organs are so temperature-sensitive that the body positions them outside its own walls.

How strong is the evidence?

Limited — small, preclinical and largely from the institute that developed the compound, with no regulatory approval anywhere.

Why are the testes outside the body?

Because sperm production requires a temperature a few degrees below core body temperature. The exposed position is a trade — evolution accepted a genuinely vulnerable location in exchange for that temperature reduction, which indicates how strict the requirement is.

How is the temperature actually regulated?

Actively. Muscles raise and lower the organ as external conditions change, and a countercurrent arrangement of blood vessels cools incoming arterial blood before it reaches the tissue. The organ runs a thermostat rather than simply sitting somewhere cooler.

Research Library›Bioregulators & Neuropeptides›Testagen

Testicular Bioregulator

Testagen: The Peptide for the Body’s Hormone Factory

A short peptide aimed at testicular tissue — an organ that is both a factory and a thermostat, and unusually sensitive to both roles.

5 min read·4 studies cited·Updated July 2026

Evidence level

Preclinical only — animal and cell studies

What this level means

Quick Reference

Type	Short peptide
Target tissue	Testes
Studied for	Androgen production, tissue function
Generation	Synthetic

What Is Testagen?

Testagen is a short peptide from the Khavinson family directed at testicular tissue, studied in the context of androgen production and reproductive function.

A factory with a thermostat, in plain language: the testes run two operations at once: producing sperm and producing testosterone. What makes them unusual is how narrow their tolerances are. They sit outside the body because the sperm-production line will not run properly at core body temperature — a couple of degrees too warm and output falls. Very few organs are so fussy that the body relocates them outside its own walls to keep them at the right temperature. That sensitivity is part of why the tissue is studied for age-related decline: a finely tuned system has more ways to drift out of tune.

What the Research Examines

Published work examines markers of testicular tissue function and androgen production in animal models, generally in the context of age-related decline.

The evidence base is small, preclinical and drawn chiefly from the originating institute. There is no regulatory approval in any jurisdiction.

A Factory That Insists on Its Own Temperature

Testicular tissue runs two operations at once: producing sperm and producing testosterone. They happen in different compartments, and the first imposes a constraint that shapes the entire anatomy.

Sperm production does not work at body temperature. It requires a few degrees cooler, which is the entire reason the organ sits outside the body rather than protected inside it. Evolution accepted a genuinely dangerous exposed position in exchange for a small temperature reduction — which tells you how strict the requirement is.

Picture a factory that had to be built outside the town walls because its machinery will not run in the heat. Everyone understands it is safer inside. It cannot be inside and still work.

Temperature is then actively managed rather than left to chance — muscles raise and lower the organ as conditions change, and a countercurrent arrangement of blood vessels cools arriving blood before it reaches the tissue. It is not merely sited in a cooler place; it runs a thermostat.

The tissue is also one of the most rapidly dividing in the body, which makes it unusually sensitive to anything interfering with cell division. High sensitivity to disruption is a recurring theme wherever tissue turns over quickly.

Frequently Asked Questions

Compiled by the Southern Pacific Labs research team. Last updated July 2026.

Browse the research range →

Published References

Khavinson VK, Malinin VV. “Gerontological Aspects of Genome Peptide Regulation.” Karger AG, Basel, 2005. Source
Anisimov VN, Khavinson VKh. “Peptide bioregulation of aging: results and prospects.” Biogerontology, 2010. PubMed
Khavinson VKh. “Peptides and Ageing.” Neuro endocrinology letters, 2002. PubMed
Fedoreyeva LI, Kireev II, Khavinson VKh, et al. “Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA.” Biochemistry. Biokhimiia, 2011. PubMed